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Sepsis is the main cause of death in burns. Early institution of antimicrobial therapy is crucial to optimize outcomes 
but superfluous therapy increases adverse events, microbial resistance, and costs. Blood cultures are the gold standard 
for diagnosis but can take 48 to 72 hours. Biomarkers are used to help sepsis diagnosis and distinction between 
Gram-negative and Gram-positive bacterial cause. The aim of this work is to evaluate procalcitonin (PCT) accuracy 
for this distinction in burn patients. Retrospective observational study of adult septic burn patients with ≥15% 
total burn surface area admitted from January 2011 to December 2014 at a Burn Unit in Portugal. A statistical 
analysis was done, evaluating the correlation between PCT levels on the day of the first positive blood culture and 
microbiological data for Gram-negative and Grand-positive bacteria. Patients with mixed bacterial and/or fungal 
blood cultures were excluded. Data were summarized by quartiles statistics. Blood cultures were positive in 189 
patients: 75 (39.7%) showed growth for Gram-negative and 114 (60.3%) for Gram-positive bacteria. Patients with 
Gram-negative bacteria have significantly higher PCT levels. Receiver operating characteristic curve analysis showed 
accuracy for Gram-negative discrimination with area under the curve = 0.687. Most elevated levels were related to 
nonfermentative Gram-negative bacteria and by Klebsiella pneumoniae and other Enterobacteriaceae. PCT levels 
were significantly higher in burn patients with Gram-negative sepsis comparing to patients with Gram-positive 
sepsis and controls. The determination of PCT levels may help the choice of empirical antimicrobial therapy while 
microbiological culture results are not available, despite not fully ensuring the desirable degree of precision.
An early and adequate antimicrobial therapy is the main step 
for the management of septic patients.1 Unfortunately, dif-
ferential diagnosis between sepsis and the systemic inflam-
matory response triggered by trauma is difficult, particularly 
in burn patients where the usual clinical signs of sepsis are 
frequently present even in the absence of microbial infec-
tion.2 For instance, burn injuries leading to upregulation 
of the hypothalamic thermal center, physiologic release of 
catecholamines and cytokines, shift of fluids and the con-
sequent cardiovascular changes, can produce hyperthermia, 
tachycardia, hypotension, etc., that are transitory and do not 
reflect any microbial invasion but just a tentative of adjust-
ment of human body systems to the changes in the homeo-
static equilibrium.
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The gold standard for sepsis diagnosis still relies on the 
microbiological growth in blood cultures,3 which can take 
as long as 48 to 72 hours, according to different facilities,4 
and the antimicrobial sensibility tests may be available even 
later. On the other hand, the adequacy of antimicrobial 
therapy is obviously related with the appropriateness of the 
chosen drugs, that is, the selection of the most efficacious 
drug against the causative microorganism. In practical terms, 
physicians have to assess the presence of sepsis in a complex 
clinical setting, with great chance of misdiagnosis (false posi-
tive or false negative), and in most cases to wait 2 days to 
confirm their suspicion, having (or not) prescribed an antimi-
crobial therapy that may be inefficacious against the causative 
bug, allowing the septic process to progress and increasing 
the likelihood of a fatal outcome. Moreover, a superfluous 
or an inappropriate antimicrobial therapy presents risks of 
adverse events for the patient and stimulates the development 
of microbial resistance, besides increasing costs.5 In conclu-
sion as described in a seminal work by Kumar et al,6 it is of 
outstanding importance the prompt institution of an effective 
antimicrobial therapy, avoiding the serious risks present when 
this is not timely done.
In the last decade, biomarkers have been employed to help 
sepsis diagnosis and antimicrobial prescription and stopping. 
Together with infection control measures and antimicrobial 
therapy protocols, the use of biomarkers constitutes the back-
bone of most antimicrobial stewardship programs.7 From a 
multitude of clinical and biochemical biomarkers described 
in literature, procalcitonin (PCT) became one of the most 
employed due to 1) its relatively good accuracy for the diag-
nosis of septic and nonseptic patients since the first hours 
of microbial invasion, helping the decision to start or post-
pone antimicrobial therapy, particularly if used in a dynamic 
approach; 2)  correlation between PCT levels and sepsis 
severity, and 3)  its rapid fall when infection is controlled.8 
Furthermore, significant differences in PCT levels have been 
found according to the causative pathogens, namely between 
Gram-negative and Gram-positive bacteria, which facilitates 
the choice of the drugs to be empirically used meanwhile 
blood culture results and sensibility tests are not available.
Even being controversial for some authors, determina-
tion of PCT serum levels has been consistently advocated for 
the diagnosis, prognosis, and antimicrobial stewardship in 
burn patients. Taking into account the different therapeutic 
approach to different pathogens, it is worthwhile to evaluate 
the discriminative potential of PCT to set the more appropri-
ate empirical therapy. The aim of this work is to size up PCT 
performance for the differential diagnosis between sepsis by 
Gram-negative and Gram-positive bacteria in a large sample 
of burn patients.
MATERIALS AND METHODS
Patient Informed Consent
Considering that this was an observational study using anony-
mized retrospective data, the Independent Ethics Committee 
(Comissão de Ética para a Saúde, Coimbra Hospital University 
Center—CHUC, Coimbra, Portugal) waived the need of 
informed consent.
Study Plan
Data for this retrospective observational study was collected 
from the clinical files and laboratory electronic records of con-
secutive burn patients with 15% or more of total burn sur-
face area, admitted from January 2011 to December 2014 at 
Coimbra Burn Unit (CBU), a department of CHUC. All the 
patients had positive blood cultures and clinical diagnosis of 
sepsis, following the American Burn Association criteria9: sus-
picion of infection coupled with the presence of three or more 
of the following parameters: temperature >39°C or <36.5°C; 
tachycardia >110 beats/min; tachypnea >25 breaths/ min 
or ventilation >12 l/min; thrombocytopenia <100,000/
ml; hyperglycemia (untreated plasma glucose > 200 mg/dl 
or intravenous glucose requirement > 7 U/h over 24 hours; 
enteral feeding intolerance: abdominal distension or gas-
tric residuals more than two times feeding rate or diarrhea 
>2500 ml.
Blood cultures were obtained in a standardized way. Three 
samples were collected by sterile venepuncture in septic 
patients. Except when immediate antimicrobial therapy has to 
be initiated due to sound clinical or laboratorial sepsis suspi-
cion, the collects were done in the morning (7–8 am). This 
collect was repeated every 2 days until clinical resolution and 
PCT normalization.
Using sample patients who never developed sepsis during 
its stay at CBU as controls, a statistical analysis was done to 
evaluate possible correlation of PCT levels on the day of the 
collection of the first positive blood culture with microbiolog-
ical data, according to two groups of microorganisms: Gram-
negative and Grand-positive bacteria. To avoid potential bias 
and simplify the analysis, patients with positive mixed bacterial 
and/or fungal blood cultures were excluded from the study. 
When a patient had more different microorganisms present in 
the blood cultures at different timepoints, only PCT levels of 
the first identification were subjected to analysis. If a patient 
had more than a PCT measurement on the day of collection, 
the highest value was used for the analysis. PCT was measured 
with TRACE© (time-resolved amplified cryptate emission) 
technology (Kryptor© PCT; Brahms© AG; Hennigsdorf, 
Germany).
Statistical Analysis
Data were summarized by quartiles statistics. The quantita-
tive variables under study showed a non-Gaussian distribu-
tion and thus a nonparametric approach (Kruskall–Wallis and 
Mann–Whitney tests) was used to compare quantitative vari-
ables. Qualitative variables were compared with the Pearson 
chi-square test. For pairwise comparisons, the Bonferroni-
correction was applied.
Receiver operating characteristic (ROC) curves, in par-
ticular the area under the curve (AUC), were performed to 
evaluate PCT ability in Gram-negative and Gram-positive dis-
crimination. Sensitivity, specificity, positive and negative pre-
dictive values were calculated for some cutoff values including 
the best cutoff defined by the maximum value of Youden 
index (J = sensitivity + specificity − 1).
Statistical analysis was performed with SPSS© 25.0 IBM© 
for Windows©. A p value of less than .05 was set as the level 
of significance and the confidence intervals are reported with 
95% confidence level.
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RESULTS
The sample under analysis was composed 438 burn patients. 
Among these patients, 249 (56.8%) did not fulfill American 
Burn Association sepsis criteria neither had any growth in their 
blood cultures during their stay at CBU, being deemed to 
serve as controls. Blood cultures were positive in 189 (43.2%) 
patients; among from these, 75 patients (39.7%) showed 
growth for Gram-negative bacteria and 114 (60.3%) showed 
growth for Gram-positive bacteria (Table 1). The median age 
was 62 years for controls, 66 years for patients with sepsis by 
Gram-negative bacteria and 69 years for patients with sepsis 
by Gram-positive bacteria; the difference among groups did 
not reach statistical significance. The same was true for gender 
distribution, which showed a preponderance of the masculine 
sex: control patients included 152 males (61%) and 97 females 
(49%); the Gram-negative group was composed by 41 males 
(55%) and 34 females (45%) meanwhile the Gram-positive 
group gathered 70 males (61%) and 44 females (39%; Table 1).
On the day of the first identification of microbiological 
growth in blood cultures, PCT levels were significantly higher 
in patients with Gram-negative bacteria comparing to con-
trols and patients with Gram-positive bacteria; the differences 
between controls and Gram-positive infected patients did not 
reach statistical significance (Table 2).
Figure 1 depicts box-plots for PCT levels in the first day of 
microbiological identification, clearly showing higher values 
for patients in the Gram-negative group in relation to con-
trol group and to Gram-positive group while the difference 
between these later groups is not evident.
The maximum value of the Youden index was 0.31, for a 
cutoff = 0.57 ng/ml. This cutoff reached a sensibility of 63% 
and a specificity of 68%; the corresponding positive predictive 
value was set in 57% and the corresponding negative predic-
tive value achieved 74% (Table 3). This was the optimum PCT 
cutoff, corresponding to the maximum point of the ROC 
curve: higher ones were associated with lesser sensitivity and 
lower ones led to loss of specificity.
ROC curve is presented in Figure 2. The AUC showed a 
significant accuracy for Gram-negative discrimination  from 
Gram-positive: AUC  =  0.687, with 95% confidence 
interval = 0.609–0.765.
Subgroup analysis was performed including the most 
frequent Gram-negative and Gram-positive microorgan-
isms responsible for sepsis in this sample of patients. In 
the Gram-negative group, the mostly frequently isolated 
agent was Pseudomonas aeruginosa, as it would be expected 
according to its great prevalence in many burn units, fol-
lowed by Acinetobacter spp. and other nonfermentative bac-
teria, including Burkholderia cepacia and Stenotrophomonas 
maltophilia. The Enterobacteriaceae were also very com-
mon, namely Escherichia coli, Enterobacter spp., Klebsiella 
pneumonia, Serratia marcescens, Proteus mirabilis, etc. 
From the Gram-positive group, Staphylococcus epidermidis, 
Staphylococcus hominis and other coagulase-negative species 
of Staphylococci, some of them without more specific iden-
tification furnished by the laboratory, were the most isolated 
from the blood samples. As it happened with Bacillus spp. and 
Corynebacterium spp., most of times the coagulase-negative 
species of Staphylococci species were suggested to be prob-
able contaminants in the microbiological results and sensibil-
ity tests. Group D Enterococci (namely Enterococcus faecalis 
and Enterococcus faecium) and Staphylococcus aureus were also 
very frequently isolated and there were also isolations of 
Streptococcus spp. Table 4 displays the list of the most common 
microorganisms and the corresponding values of PCT levels 
on the first day of microbiological identification. The full list 
can be found in Supplementary Annex I.
Despite the presence of several outliers, it was found that 
PCT levels in the Gram-negative group were in general signif-
icantly higher comparing to controls, what did not happen in 
the Gram-positive group, with the exception of patients with 
sepsis due to Streptococcus spp. (Figure 3). With the exception 
of those with sepsis due to this Gram-positive species, which 
isolation is rare ate CBU, in almost all patients with PCT con-
centrations above 3.00 ng/ml on the day of collection of the 
first positive blood culture, the causative microorganism was a 
Gram-negative agent.
In the first case, the statistical difference was more pro-
nounced for glucose nonfermenting bacilli (particularly 
Acinetobacter, Pseudomonas, and Burkholderia spp.) and for 
E. coli and K. pneumoniae, glucose fermenting rods from the 
Enterobacteriaceae family. Among patients with sepsis due to 
Gram-positive cocci, PCT levels only reach statistically signifi-
cant difference for Streptococcus spp., as referred, but there was 
a trend for significance for Enterococcus spp. and for S. aureus 
(not visible for nonaureus species).
DISCUSSION
The statistical analysis of PCT levels on the first day of micro-
biological identification in blood samples in this sample 
Table 1. Population characteristics
Controls Gram-Negative Sepsis Gram-Positive Sepsis P
Number of Patients 249 75 114 —
Age (years)
Median 62.0 66.0 69.0
.392*Q1–Q3 45.5–78.0 44.5–79.5 47–80.0
Sex
Males 152 (61%) 41 (55%) 70 (61%)
.578†Females 97 (49%) 34 (45%) 44 (39%)
Procalcitonin 
(ng/ml)
Median 0.20 0.75 0.32 .000*
Q1–Q3 0.11–0.84 0.35–4.15 0.16–0.87
*Kruskall–Wallis test.
†Chi-square test.
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of extensively burned patients confirmed previous reports 
demonstrating significantly higher values in the presence of 
Gram-negative bacteria comparing with controls or patients 
with Gram-positive sepsis.10–13 The difference was most pro-
nounced when causative agents were glucose nonfermenting 
bacilli, particularly Acinetobacter and Pseudomonas spp., or 
Enterobacteriaceae rods, like E.  coli or K.  pneumoniae. On 
the other hand, a statistical difference in PCT levels was not 
found between in PCT levels of patients with sepsis caused by 
Gram-positive bacteria and control patients, with the excep-
tion of patients with sepsis caused by Streptococcus spp.
The results of this work are consistent with medical litera-
ture. Opal and Cohen14 attributed the different characteris-
tics of sepsis caused by Gram-negative and Gram-positive to 
the different constitution of their respective cell membranes, 
which will trigger different immunological responses and are, 
in most part, correlated with diverse clinical presentations 
and outcomes.15 Briefly explaining, despite there is not yet 
a full understanding of the mechanisms involved in cytokines 
activation following microbial insult, it is consensual that 
human innate immune cells (macrophages, neutrophils, den-
dritic cells) have receptors, present either on the external cell 
membrane or inside the cytoplasm (endosomes) which are 
apt to recognize specific circulating molecular patterns. These 
pattern recognition receptors (PRRs) can be activated by 
molecular patterns resulting from nonmicrobial tissue dam-
age (damage-associated molecular patterns,  DAMPs) or by 
those exclusively corresponding to microbial pathogenic com-
ponents (pathogen-associated molecular patterns, PAMPs).16 
The interaction between PRRs and PAMPs induces the release 
of cytokines by immune cells, initiating the septic process.
There are several types of PRRs, including Toll-like recep-
tors (TLRs) and NOD-like receptors—mainly activated 
by bacteria; RIG-I-like receptors and DNA-sensing mol-
ecules—crucial for sensing of viruses; C-type lectin receptors 
responding to fungi and mycobacteria PAMPs; etc. The outer 
membrane of Gram-negative bacteria cell wall is composed 
mostly by lipopolysaccharide, frequently referred as endotox-
ine, which is its principal PAMP, being recognized by TLR4.17 
Instead of lipopolysaccharide, PAMPs of Gram-positive bacte-
ria cell wall are basically lipoteichoic acid,18 lipoproteins and 
proteoglicans, mostly sensed by TLR2.
TLR4 activation triggers a strong release of inflammatory 
cytokines, namely tumor-necrosis factor α, interleukin-1, and 
interleukin-6.19 These cytokines will promote gene transcrip-
tion leading to PCT secretion from extrathyroidal tissues, with 
abrupt rise of its blood levels. It was also described a direct 
stimulation of PCT secretion by circulating endotoxins.20 On 
the other hand, TLR2 activation usually induces a relatively 
weaker and not always straightforward production of those 
cytokines, varying according to different pathogens by not 
well known reasons.
In 2008, Charles and colleagues analyzed the accuracy of 
PCT measurements to discriminate between Gram-negative 
and Gram-positive bacteremia at the onset of bloodstream 
infection, concluding that serum levels were greater in the 
Figure 1. Box-plots for procalcitonin levels in controls (n = 249), Gram-negative (n = 75), and Gram-positive (n = 114) sepsis patients groups.
Table 3. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of procalcitonin cutoffs for 
the distinction between Gram-negative and Gram-positive sepsis in burn patients
Cutoff Sensitivity (%) Specificity (%) PPV (%) NPV (%) Youden Obs.
0.50 64 62 53 72 0.26
0.57 63 68 57 74 0.31 Max. Youden
1.00 46 76 52 71 0.22
5.00 23 92 62 68 0.15
Table 2. Pairwise comparisons for procalcitonin levels 
between sepsis groups
Comparison P
Gram-negative septic patients vs controls .000
Gram-negative septic patients vs Gram-positive septic patients .000
Gram-positive septic patients vs controls .153
Mann–Whitney test with Bonferroni-corrected P-values.
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first group, with an AUC of 0.79, opposing to what happened 
with the measurements of C-reactive protein and leucocyte 
counting.21 As PCT levels determination is available sooner 
than Gram stain results and microbiological identification, 
these authors suggest this information should be taking in 
account when choosing empirical antibiotherapy for sepsis.
In 2012, Jeong et al,22 showed a good performance of PCT 
in the distinction between patients with negative and positive 
blood cultures, facilitating the differentiation of true blood-
stream infections from contamination. They also reported 
that significantly higher values were found for Gram-negative 
bacteremia comparing to Gram-positive or fungal ones, what 
did not happen with C-reactive protein values. With most 
patients coming from hematological ICUs, an article by 
Brodská et al23 described significantly higher PCT values for 
patients with Gram-negative bacterial infections, comparing 
to Gram-positive or fungal infections, meanwhile no statistical 
difference was found between these latter two groups. They 
concluded that PCT levels could be used to help the confir-
mation or exclusion of Gram-negative sepsis. Nakajima et al,24 
presented similar results in 2014, speculating the possibility of 
using PCT levels to help antimicrobial empiric antibiotherapy.
In 2015, Oussalah et al25 using a comprehensive electronic 
database, performed an observational cross-sectional study 
and analyzing 2699 patients with positive blood cultures, 
found statistically higher PCT levels in patients with Gram-
negative sepsis comparing patients with Gram-positive sepsis, 
with most elevate values for Escherichia spp., Bacteroides spp., 
Klebsiella spp. and Enterobacter spp. They also pointed values 
under 0.75 ng/ml as very effective for exclusion of most clini-
cal relevant pathogens, meanwhile a cutoff above 10 ng/ml 
practically excluded the hypothesis of sample contamination or 
fungal infection. In a prospective study, including 1949 adult 
patients with positive blood cultures, Leli et al26 also reported 
significantly higher PCT levels for Gram-negative infections, 
more pronounced for Enterobacteriaceae bacteria, suggesting 
a cutoff of 3.1 ng/ml for the exclusion of these microorgan-
isms. Guo et al27 reached the same results in a sample of 280 
septic patients and listed Klebsiella, Escherichia, Acinetobacter, 
Enterobacter, and Pseudomonas as the pathogenic species 
responsible for higher PCT levels. In 2016, Li et al28 analyz-
ing 328 septic episodes, suggested that PCT levels might be 
used as a surrogate marker to distinguish sepsis cases origi-
nated by Gram-negative bacteria from the ones deriving from 
Gram-positive bacterial or fungal invasion of bloodstream, 
proposing a cutoff of 2.44 ng/ml. Yan et al29 reviewed data 
from 484 monomicrobial positive blood cultures of septic 
patients (75% collected at the ICU and 25% at the Emergency 
Department), reporting statistically significant differences 
in PCT levels, with higher values corresponding to patients 
Figure  2. Receiver operating characteristic curve for procalcitonin 
accuracy in the distinction between Gram-negative and Gram-positive 
bacterial sepsis in burn patients (cutoff = 0.57 ng/ml).
Table 4. Procalcitonin values for the most frequently isolated groups of microorganisms in blood samples of septic burn patients
Microorganism Number Median Q1 Q3 P
Controls 249 0.20 0.11 0.84
Glucose nonfermenting Gram-negative Bacilli
Acinetobacter spp. 13 1.17 0.49 7.30 .002
Pseudomonas spp. 13 0.67 0.39 1.68 .005
Burkholderia cepacia 4 1.82 0.89 3.05 .045
Xanthomonas maltophilia 4 0.63 0.29 8.89 .241
Enterobacteriaceae
Enterobacter 9 0.55 0.22 0.62 .087
Escherichia coli 5 2.96 0.75 6.90 .020
Klebsiella pneumoniae 5 1.77 0.58 22.18 .043
Serratia marscecens 5 0.75 0.48 0.89 .255
Gram-positive Cocci
Enterococcus spp. 12 0.38 0.18 0.73 .177
Staphylococcus aureus 11 0.28 0.21 0.97 .185
Staphylococcus (except aureus) 54 0.29 0.11 0.88 .668
Streptococcus spp. 8 2.18 1.27 4.91 .003
Mann–Whitney test (comparison with control).
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with Gram-negative infection. From the Gram-negative bac-
terial sepsis group, PCT levels were more pronounced for 
Enterobacteriaceae microorganisms (E.  coli, Kebsiella spp., 
Enterobacter spp., and Serratia spp., by this order), which 
presented relatively higher values than glucose nonfermenting 
Gram-negative bacilli (P.  aeruginosa, Acinetobacter bauma-
nii, S. maltophilia, B. cepacia, etc.). From the Gram-positive 
bacterial sepsis group, patients infected by Streptococcus spp., 
Enteroccoccus spp., and S. aureus had the most elevated PCT 
concentrations. The authors defended that PCT could be use-
ful not only to distinguish between Gram-negative and Gram-
positive sepsis, but might even be employed to identify diverse 
species inside each of these groups of microorganisms.
In a work from 2018, Thomas-Rüddel et al performed a sec-
ondary analysis of a prospectively collected dataset, including a 
very large sample with 4858 septic patients from 40 hospitals. 
Their results were very similar to the present study, showing 
distinctly higher values for PCT concentrations in patients with 
Gram-negative bacteremia than in patients with sepsis result-
ing from Gram-positive or fungal systemic invasion.30 Indeed, 
the AUC for the discrimination of Gram-negative sepsis from 
Gram-positive was identical, is spite substantially diverse cut-
offs. Subgroups of pathogens with the most elevated values 
were also very close, with Streptococcus spp.; E.  coli, Proteus 
spp., K. pneumoniae and other Enterobacteriaceae on the top. 
The authors referred, however, a large overlap of PCT levels 
and speculate that higher values may be more related with 
higher bacterial load and potentially with intrinsic character-
istics of pathogens groups, considering the discriminatory 
power too low to guide therapeutic decisions.
Burn patients have a risk of infection superior to the aver-
age critical care patient and sepsis diagnosis is more difficult31 
due to the intense inflammatory systemic response unleashed 
by the  burn insult per se. In these patients, PCT measure-
ments, particularly using a kinetic approach, have being 
increasingly advocated by many authors to help the differ-
entiation between pure inflammatory reaction and microbial 
infection32–36 and for antimicrobial stewardship.37 However, 
this strategy is still not fully accepted38–42 in spite of systematic 
reviews and meta-analysis suggesting its validity.43–45 In 2012, 
a study of Lavrentieva et al,46 including 86 burn patients, was 
presumably the first work reporting statistically significant 
differences of PCT levels between burn patients with Gram-
negative sepsis and those with Gram-positive sepsis, with the 
most elevated values in the former group. Mokline et  al in 
a paper of 2015,47 including 44 patients, confirmed these 
results.
To the authors’ knowledge, the present work, with 189 
septic burn patients, from a homogenous population, cor-
responds to the largest sample already analyzed in medical 
literature regarding this subject. It confirms previous reports 
and, moreover, it further details subgroups differences. On 
its strengths one can also count the use of strict and inter-
nationally validated criteria for definition of burn sepsis, as 
well as the exclusive utilization of microbiological positive 
bloodstream cultures, collected in a standardized way, avoid-
ing potential bias due to the use of other types of biologi-
cal samples. The results of this study, with PCT showing a 
fair capacity for the distinction between Gram-negative and 
Gram-positive sepsis insinuate the possibility of using its val-
ues in face of sound suspicion of sepsis in burn patients to help 
the choice of empirical therapy until definitive microbiological 
identification is available. Cutoffs will be clearly dependent on 
the idiosyncratic characteristics from each facility, depending 
on its nosocomial flora and its patients and cannot be gener-
alizable. However very high PCT levels (for instance, above 
3.00 or 5.00 ng/ml) would usually be more associated with 
Gram-negative sepsis, with fair positive predictive value and 
negative predictive value, and good specificity in spite outliers 
may be present. Also, in the great majority of the cases, PCT 
values under 0.5 ng/ml will not correspond to Gram-negative 
infections but to Gram-positive or fungal ones.
Paying attention that the majority of deaths in burn 
patients result from infectious episodes and sepsis48 is clear 
that prompt, adequate and appropriate selection of antimi-
crobial therapy is crucial for the outcome of these high risk 
patients. On the other hand, potential damages from adverse 
events and the contribution to the development of microbial 
resistance due to superfluous antimicrobial therapy must be 
duly considered. Meanwhile faster methods of microbiologi-
cal identification, such as polymerase chain reaction,49 mass 
spectrometry ionization (Matrix-Assisted Laser Desorption 
Ionization–Time of Flight), gene expression profiling, aptam-
ers panels, etc.,50 or even more sophisticated and individual-
ized system-based ones (integrating genomics, metabolomics, 
and proteomics data), are not either widely available or fully 
developed,51–53 PCT dosing will remain one of the more use-
ful tools to help clinicians decisions.5,54,55
Figure 3. Box-plots for procalcitonin levels in Gram-negative and Gram-positive bacterial sepsis subgroups.
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For these reasons, in the authors’ opinion, it is worthwhile 
to use PCT measurements to have a more empowered pre-
scription decision, even bearing in mind that the analysis of its 
levels does not fully ensure the desirable degree of precision.
The present work has manifestly some limitations that should 
be noticed. First, being a retrospective study it is more prone 
to selection bias than a prospective one. On the other hand, 
all patients enrolled came from the same center, so the results 
obtained may not be exactly reproduced in other Burn Units. 
Subgroup analysis according to associated pathologies was not 
done, neither the results from other current biomarkers like 
CRP or leucocyte counting were noted. However, according to 
the available literature, the relevance of these biomarkers is at 
least very questionable for the purposes of this study. Due to the 
small number of positive blood samples with fungi found during 
the study period, comparison with PCT levels in Gram-negative 
and Gram-positive sepsis was not done. To avoid confusion, 
mixed infections were purposely not included. It would also had 
been very interesting to further extend the analysis of PCT levels 
to the subsequent days after the positivation of blood samples, 
assessing the potential added value of PCT kinetics regarding 
distinction of different types of bacterial infection.
CONCLUSIONS
This retrospective study consistently showed the presence 
higher PCT levels in burn patients with Gram-negative sep-
sis, suggesting that PCT may help clinicians in the choice of 
the empirical antimicrobial therapy, while the definitive, gold 
standard, microbiological culture results and sensibility tests 
are not yet available. However, it should be emphasized that 
PCT must be integrated within the clinical context and the 
facility prevalent flora, and it can never substitute clinicians’ 
evaluation and judgment. Prospective multicentric studies are 
needed to get a stronger validation of the use of PCT values 
for the distinction between Gram-negative and Gram-positive 
bacterial sepsis and it would be also desirable to include fungal 
and mixed infections. Evaluation of PCT kinetics potential for 
differential diagnosis between microbial sepsis due to diverse 
types of pathogens would also be very interesting and poten-
tially useful for clinical practice.
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